Discover the intricacies of mRNA and its rapidly advancing technologies with the assistance of KnowMade’s patent expertise.
- Gain access to valuable insights on the latest mRNA patent news at no cost.
- Delve deeper into the field with our comprehensive reports.
- Stay at the forefront of research and development and intellectual property advancements through our monitoring services.
Insights
SOPHIA ANTIPOLIS, France – May 13, 2024 │ KnowMade actively follows therapeutic mRNA news for its Therapeutic mRNA patent monitor service! What’s new today? REPLICATE [...]
SOPHIA ANTIPOLIS, France – January 22, 2024 │ The quarterly report for the Q4 2023 Therapeutic mRNA patent monitor is now available! This report covers [...]
SOPHIA ANTIPOLIS, France – January 16, 2024 │ The last quarterly report for the 2023 Therapeutic mRNA patent monitor is now available! This report covers [...]
SOPHIA ANTIPOLIS, France – November 15, 2023 │ KnowMade’s Therapeutic mRNA Patent Monitor was presented at the 11th mRNA health conference in Berlin (October 31 [...]
SOPHIA ANTIPOLIS, France – November 06, 2023 │ReNAgadeTherapeutics, a company founded in 2021 and based in Cambridge, presented preclinical data demonstrating a new and proprietary [...]
SOPHIA ANTIPOLIS, France – October 25, 2023 │ The quarterly report for the Q3 2023 Therapeutic mRNA patent monitor is now available! This report covers [...]
Reports
![]() |
![]() |
![]() |
Self-amplifying RNA vaccines Patent Landscape Analysis 2023 | mRNA Cancer Therapies Patent Landscape Analysis 2022 | RNA vaccine Patent Landscape 2021 |
Monitor
![]() |
Therapeutic mRNA Patent Monitor |